Effect of zinc supplementation on neurodevelopment and growth in late preterm- a hospital based randomised controlled study
Not Applicable
- Registration Number
- CTRI/2023/06/053625
- Lead Sponsor
- Dr Nikitha Suvarna J
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Infants born late preterm (gestational age 34weeks - <37 weeks) with low birth weight ( birth weight <2500g)
2.Received breast milk exclusively during the study period.
3. Infants who take enteral feeds by 3rd day of life
Exclusion Criteria
• Infants with congenital anomalies/ malformations
• Infants who underwent GI surgery during initial hospital/ GI malformation or any
condition accompanied by abnormal losses of GI juices
• Infants kept nil per oral for longer than 3 days of life
• Infants on formula feeds
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of zinc supplementation on neurological development & growth <br/ ><br>of late preterm neonates <br/ ><br>Timepoint: 3 months corrected gestational age
- Secondary Outcome Measures
Name Time Method 1. To determine association of serum zinc levels & morbidities <br/ ><br>2.To assess the correlation of serum copper to serum zinc levelsTimepoint: 3 months corrected gestational age